Share Price and Basic Stock Data
Last Updated: November 28, 2025, 8:17 am
| PEG Ratio | 0.50 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Himadri Speciality Chemical Ltd operates in the specialty chemicals sector, focusing on manufacturing a range of products that cater to various industries. The company reported a revenue of ₹4,172 Cr for the fiscal year ending March 2023, which rose to ₹4,185 Cr in March 2024 and reached ₹4,613 Cr in March 2025. Notably, the trailing twelve months (TTM) revenue stood at ₹4,465 Cr, showcasing a consistent upward trajectory. Quarterly sales exhibited fluctuations, with a peak of ₹1,177 Cr in March 2024, and a subsequent sales trend indicating recovery, reaching ₹1,200 Cr in June 2024. The company’s operating profit margin (OPM) improved significantly from 10% in March 2023 to 19% in March 2025, reflecting operational efficiency and robust demand for its product offerings. This growth trajectory positions Himadri as a competitive player in the specialty chemicals market, which is projected to grow at a CAGR of around 11% until 2025, according to industry reports.
Profitability and Efficiency Metrics
Himadri’s profitability metrics underscore its operational effectiveness. The net profit for the fiscal year ending March 2025 was reported at ₹555 Cr, a substantial increase from ₹216 Cr in March 2023. The earnings per share (EPS) also witnessed a remarkable rise, reaching ₹11.25 in March 2025 from ₹4.99 in March 2023. The company’s return on equity (ROE) stood at 16.4%, while the return on capital employed (ROCE) was reported at 22%, indicating efficient capital utilization. Furthermore, the interest coverage ratio (ICR) was an impressive 20.23x, demonstrating the company’s ability to meet interest obligations comfortably. The cash conversion cycle of 90 days reflects efficient working capital management, although it is slightly higher than typical sector norms, which often range between 30 to 60 days. Overall, these metrics reflect a strong profitability profile and efficient operational management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Himadri Speciality Chemical Ltd exhibits solid financial health, with total assets reported at ₹4,656 Cr as of March 2025. The company holds reserves of ₹3,672 Cr, which has grown from ₹2,237 Cr in March 2023, indicating robust retained earnings and financial resilience. Borrowings stood at ₹313 Cr, significantly reduced from ₹842 Cr in March 2023, reflecting prudent debt management. The debt-to-equity ratio is a manageable 0.08, indicating low leverage compared to industry standards. The current ratio, reported at 3.56, highlights strong liquidity, well above the typical benchmark of 1.5. Additionally, the price-to-book value (P/BV) ratio is 5.62, suggesting a premium valuation relative to its book value, which stands at ₹75.37 per share. These figures underscore Himadri’s strong balance sheet and financial stability, positioning it favorably for future growth opportunities.
Shareholding Pattern and Investor Confidence
The shareholding structure of Himadri Speciality Chemical Ltd reflects a balanced mix of promoter and public ownership, with promoters holding 52.50% of the shares as of November 2025. This is an increase from 44.96% in June 2023, indicating growing confidence from the promoters in the company’s future prospects. Foreign institutional investors (FIIs) accounted for 5.62% of the shareholding, while domestic institutional investors (DIIs) held 3.18%. The public shareholding stood at 38.69%, showcasing a strong retail investor base with 4,44,893 shareholders reported. This diverse ownership structure is a positive signal for investor confidence. However, the recent decline in public shareholding from 51.54% in March 2023 to 38.69% in November 2025 could raise concerns about retail investor sentiment. The increasing promoter stake, however, may counterbalance these concerns by demonstrating commitment to the company’s growth.
Outlook, Risks, and Final Insight
Looking ahead, Himadri Speciality Chemical Ltd appears well-positioned for continued growth, supported by robust demand in the specialty chemicals sector and improving profitability metrics. However, risks remain, including fluctuations in raw material prices, which could impact margins, and potential regulatory challenges that may arise in the chemicals industry. The company’s high P/E ratio of 34.3 suggests that the stock is trading at a premium, which may lead to volatility if earnings do not meet market expectations. Additionally, the slightly elongated cash conversion cycle compared to industry norms could pose liquidity risks if not managed effectively. Overall, while Himadri has demonstrated strong operational performance and financial health, maintaining a keen focus on cost management and market conditions will be crucial for sustaining its growth trajectory. The balance between leveraging growth opportunities and mitigating risks will ultimately define the company’s success in the competitive landscape of specialty chemicals.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Himadri Speciality Chemical Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 403 Cr. | 43.9 | 86.7/42.2 | 25.0 | 20.5 | 0.89 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 34.4 Cr. | 70.0 | 103/56.0 | 16.4 | 89.6 | 1.43 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 45.2 Cr. | 665 | 988/600 | 20.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,634 Cr. | 80.2 | 111/78.0 | 24.1 | 22.0 | 0.63 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 655 Cr. | 263 | 453/241 | 23.5 | 93.8 | 0.95 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,770.36 Cr | 732.50 | 63.16 | 183.02 | 0.43% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,047 | 1,059 | 1,037 | 1,029 | 951 | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 | 1,135 | 1,118 |
| Expenses | 975 | 962 | 932 | 903 | 817 | 847 | 879 | 997 | 1,008 | 929 | 920 | 901 | 873 |
| Operating Profit | 72 | 97 | 105 | 126 | 134 | 158 | 174 | 180 | 192 | 208 | 221 | 233 | 245 |
| OPM % | 7% | 9% | 10% | 12% | 14% | 16% | 17% | 15% | 16% | 18% | 19% | 21% | 22% |
| Other Income | 2 | -22 | 8 | 11 | 10 | 10 | 10 | 12 | 13 | 14 | 12 | 14 | 27 |
| Interest | 13 | 20 | 20 | 13 | 13 | 16 | 21 | 14 | 13 | 11 | 12 | 9 | 16 |
| Depreciation | 13 | 13 | 13 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 15 |
| Profit before tax | 48 | 42 | 79 | 111 | 119 | 139 | 150 | 166 | 179 | 197 | 206 | 224 | 241 |
| Tax % | 20% | 15% | 18% | 31% | 28% | 28% | 28% | 30% | 31% | 31% | 31% | 31% | 26% |
| Net Profit | 39 | 36 | 65 | 76 | 86 | 101 | 109 | 115 | 123 | 136 | 141 | 155 | 179 |
| EPS in Rs | 0.92 | 0.86 | 1.55 | 1.76 | 1.96 | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 | 2.88 | 3.15 | 3.68 |
Last Updated: August 1, 2025, 8:05 pm
Below is a detailed analysis of the quarterly data for Himadri Speciality Chemical Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,118.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,135.00 Cr. (Mar 2025) to 1,118.00 Cr., marking a decrease of 17.00 Cr..
- For Expenses, as of Jun 2025, the value is 873.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 901.00 Cr. (Mar 2025) to 873.00 Cr., marking a decrease of 28.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 245.00 Cr.. The value appears strong and on an upward trend. It has increased from 233.00 Cr. (Mar 2025) to 245.00 Cr., marking an increase of 12.00 Cr..
- For OPM %, as of Jun 2025, the value is 22.00%. The value appears strong and on an upward trend. It has increased from 21.00% (Mar 2025) to 22.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 27.00 Cr., marking an increase of 13.00 Cr..
- For Interest, as of Jun 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 7.00 Cr..
- For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 241.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2025) to 241.00 Cr., marking an increase of 17.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 31.00% (Mar 2025) to 26.00%, marking a decrease of 5.00%.
- For Net Profit, as of Jun 2025, the value is 179.00 Cr.. The value appears strong and on an upward trend. It has increased from 155.00 Cr. (Mar 2025) to 179.00 Cr., marking an increase of 24.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.68. The value appears strong and on an upward trend. It has increased from 3.15 (Mar 2025) to 3.68, marking an increase of 0.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,395 | 1,437 | 1,182 | 1,341 | 2,022 | 2,422 | 1,806 | 1,679 | 2,791 | 4,172 | 4,185 | 4,613 | 4,465 |
| Expenses | 1,307 | 1,313 | 1,036 | 1,107 | 1,569 | 1,863 | 1,525 | 1,549 | 2,635 | 3,773 | 3,540 | 3,758 | 3,533 |
| Operating Profit | 88 | 124 | 146 | 233 | 452 | 560 | 280 | 131 | 156 | 399 | 645 | 854 | 932 |
| OPM % | 6% | 9% | 12% | 17% | 22% | 23% | 16% | 8% | 6% | 10% | 15% | 19% | 21% |
| Other Income | 13 | 13 | 9 | 6 | 12 | 8 | 8 | 14 | -17 | -2 | 43 | 52 | 88 |
| Interest | 118 | 103 | 111 | 82 | 70 | 71 | 55 | 33 | 36 | 66 | 64 | 45 | 51 |
| Depreciation | 58 | 59 | 67 | 33 | 33 | 34 | 39 | 47 | 50 | 51 | 50 | 55 | 61 |
| Profit before tax | -75 | -24 | -23 | 125 | 361 | 462 | 194 | 65 | 53 | 280 | 574 | 806 | 908 |
| Tax % | -22% | -49% | -19% | 34% | 31% | 30% | -6% | 27% | 27% | 23% | 28% | 31% | |
| Net Profit | -58 | -13 | -19 | 82 | 248 | 324 | 205 | 47 | 39 | 216 | 411 | 555 | 652 |
| EPS in Rs | -1.48 | -0.32 | -0.44 | 1.98 | 5.91 | 7.75 | 4.91 | 1.13 | 0.98 | 4.99 | 8.34 | 11.25 | 13.28 |
| Dividend Payout % | -7% | 0% | -11% | 5% | 2% | 2% | 3% | 13% | 20% | 5% | 6% | 5% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 77.59% | -46.15% | 531.58% | 202.44% | 30.65% | -36.73% | -77.07% | -17.02% | 453.85% | 90.28% | 35.04% |
| Change in YoY Net Profit Growth (%) | 0.00% | -123.74% | 577.73% | -329.14% | -171.79% | -67.37% | -40.34% | 60.05% | 470.87% | -363.57% | -55.24% |
Himadri Speciality Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 21% |
| 3 Years: | 18% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 22% |
| 3 Years: | 111% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 53% |
| 3 Years: | 65% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 15% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 6:10 am
Balance Sheet
Last Updated: November 9, 2025, 2:10 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 | 49 | 49 | 49 |
| Reserves | 757 | 750 | 837 | 988 | 1,373 | 1,590 | 1,692 | 1,751 | 1,826 | 2,237 | 2,996 | 3,672 | 4,020 |
| Borrowings | 1,362 | 1,124 | 887 | 774 | 660 | 476 | 505 | 729 | 587 | 842 | 605 | 313 | 864 |
| Other Liabilities | 339 | 329 | 296 | 308 | 341 | 680 | 323 | 269 | 999 | 555 | 798 | 621 | 585 |
| Total Liabilities | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 5,518 |
| Fixed Assets | 1,221 | 1,228 | 1,180 | 1,174 | 1,178 | 1,170 | 1,475 | 1,468 | 1,546 | 1,515 | 1,534 | 1,605 | 1,663 |
| CWIP | 59 | 14 | 31 | 13 | 22 | 133 | 158 | 160 | 77 | 94 | 67 | 185 | 443 |
| Investments | 168 | 23 | 53 | 87 | 273 | 179 | 47 | 66 | 113 | 132 | 478 | 582 | 723 |
| Other Assets | 1,048 | 977 | 798 | 838 | 943 | 1,305 | 882 | 1,098 | 1,718 | 1,938 | 2,371 | 2,283 | 2,688 |
| Total Assets | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 5,518 |
Below is a detailed analysis of the balance sheet data for Himadri Speciality Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 49.00 Cr..
- For Reserves, as of Sep 2025, the value is 4,020.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,672.00 Cr. (Mar 2025) to 4,020.00 Cr., marking an increase of 348.00 Cr..
- For Borrowings, as of Sep 2025, the value is 864.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 313.00 Cr. (Mar 2025) to 864.00 Cr., marking an increase of 551.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 585.00 Cr.. The value appears to be improving (decreasing). It has decreased from 621.00 Cr. (Mar 2025) to 585.00 Cr., marking a decrease of 36.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,518.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,656.00 Cr. (Mar 2025) to 5,518.00 Cr., marking an increase of 862.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,663.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,605.00 Cr. (Mar 2025) to 1,663.00 Cr., marking an increase of 58.00 Cr..
- For CWIP, as of Sep 2025, the value is 443.00 Cr.. The value appears strong and on an upward trend. It has increased from 185.00 Cr. (Mar 2025) to 443.00 Cr., marking an increase of 258.00 Cr..
- For Investments, as of Sep 2025, the value is 723.00 Cr.. The value appears strong and on an upward trend. It has increased from 582.00 Cr. (Mar 2025) to 723.00 Cr., marking an increase of 141.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,688.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,283.00 Cr. (Mar 2025) to 2,688.00 Cr., marking an increase of 405.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,518.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,656.00 Cr. (Mar 2025) to 5,518.00 Cr., marking an increase of 862.00 Cr..
Notably, the Reserves (4,020.00 Cr.) exceed the Borrowings (864.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 87.00 | 123.00 | -741.00 | -541.00 | -208.00 | 84.00 | -225.00 | -598.00 | -431.00 | -443.00 | 40.00 | 541.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 82 | 63 | 60 | 49 | 55 | 61 | 100 | 66 | 44 | 57 | 50 |
| Inventory Days | 134 | 122 | 138 | 164 | 112 | 124 | 121 | 100 | 125 | 61 | 85 | 68 |
| Days Payable | 36 | 36 | 50 | 74 | 39 | 100 | 68 | 45 | 127 | 39 | 69 | 28 |
| Cash Conversion Cycle | 191 | 168 | 151 | 150 | 122 | 79 | 113 | 155 | 65 | 66 | 73 | 90 |
| Working Capital Days | -11 | 4 | -22 | 19 | 29 | 40 | 10 | 15 | -1 | 1 | 32 | 69 |
| ROCE % | 2% | 3% | 5% | 11% | 22% | 25% | 11% | 4% | 5% | 13% | 19% | 22% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 230,983 | 1.2 | 5.51 | 230,983 | 2025-04-22 17:25:32 | 0% |
| Groww Nifty Total Market Index Fund | 539 | 0.04 | 0.01 | 539 | 2025-04-22 17:25:32 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 11.26 | 9.16 | 5.13 | 0.98 | 1.13 |
| Diluted EPS (Rs.) | 11.17 | 9.16 | 5.13 | 0.98 | 1.13 |
| Cash EPS (Rs.) | 12.35 | 9.35 | 6.16 | 2.11 | 2.25 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Revenue From Operations / Share (Rs.) | 93.41 | 84.96 | 96.41 | 66.62 | 40.09 |
| PBDIT / Share (Rs.) | 18.35 | 13.96 | 9.87 | 3.90 | 3.46 |
| PBIT / Share (Rs.) | 17.23 | 12.95 | 8.70 | 2.71 | 2.34 |
| PBT / Share (Rs.) | 16.33 | 11.65 | 6.48 | 1.28 | 1.54 |
| Net Profit / Share (Rs.) | 11.24 | 8.34 | 4.99 | 0.93 | 1.13 |
| NP After MI And SOA / Share (Rs.) | 11.25 | 8.34 | 4.99 | 0.97 | 1.13 |
| PBDIT Margin (%) | 19.63 | 16.43 | 10.23 | 5.84 | 8.63 |
| PBIT Margin (%) | 18.44 | 15.23 | 9.02 | 4.07 | 5.83 |
| PBT Margin (%) | 17.47 | 13.71 | 6.71 | 1.91 | 3.84 |
| Net Profit Margin (%) | 12.03 | 9.81 | 5.17 | 1.39 | 2.81 |
| NP After MI And SOA Margin (%) | 12.04 | 9.81 | 5.17 | 1.46 | 2.82 |
| Return on Networth / Equity (%) | 14.92 | 13.48 | 9.47 | 2.19 | 2.64 |
| Return on Capital Employeed (%) | 21.00 | 19.64 | 15.48 | 5.57 | 5.02 |
| Return On Assets (%) | 11.93 | 9.23 | 5.87 | 1.18 | 1.70 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 |
| Total Debt / Equity (X) | 0.08 | 0.19 | 0.36 | 0.30 | 0.37 |
| Asset Turnover Ratio (%) | 1.01 | 1.03 | 1.17 | 0.90 | 0.63 |
| Current Ratio (X) | 3.56 | 1.92 | 1.51 | 1.18 | 1.25 |
| Quick Ratio (X) | 2.59 | 1.33 | 1.07 | 0.63 | 0.84 |
| Inventory Turnover Ratio (X) | 4.90 | 4.92 | 4.99 | 4.30 | 3.13 |
| Dividend Payout Ratio (NP) (%) | 4.44 | 2.63 | 3.88 | 15.34 | 13.23 |
| Dividend Payout Ratio (CP) (%) | 4.04 | 2.34 | 3.14 | 6.94 | 6.65 |
| Earning Retention Ratio (%) | 95.56 | 97.37 | 96.12 | 84.66 | 86.77 |
| Cash Earning Retention Ratio (%) | 95.96 | 97.66 | 96.86 | 93.06 | 93.35 |
| Interest Coverage Ratio (X) | 20.23 | 10.77 | 6.47 | 4.58 | 4.34 |
| Interest Coverage Ratio (Post Tax) (X) | 13.40 | 7.43 | 4.72 | 2.79 | 2.41 |
| Enterprise Value (Cr.) | 20619.97 | 14725.34 | 3988.71 | 3425.68 | 2287.01 |
| EV / Net Operating Revenue (X) | 4.47 | 3.52 | 0.95 | 1.23 | 1.36 |
| EV / EBITDA (X) | 22.76 | 21.42 | 9.34 | 20.98 | 15.78 |
| MarketCap / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| Retention Ratios (%) | 95.55 | 97.36 | 96.11 | 84.65 | 86.76 |
| Price / BV (X) | 5.62 | 4.88 | 1.66 | 1.67 | 0.97 |
| Price / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| EarningsYield | 0.02 | 0.02 | 0.05 | 0.01 | 0.02 |
After reviewing the key financial ratios for Himadri Speciality Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.26. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.26, marking an increase of 2.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.17. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.17, marking an increase of 2.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.35. This value is within the healthy range. It has increased from 9.35 (Mar 24) to 12.35, marking an increase of 3.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 93.41. It has increased from 84.96 (Mar 24) to 93.41, marking an increase of 8.45.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.35. This value is within the healthy range. It has increased from 13.96 (Mar 24) to 18.35, marking an increase of 4.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 17.23, marking an increase of 4.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 16.33, marking an increase of 4.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.24. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.24, marking an increase of 2.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.25. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.25, marking an increase of 2.91.
- For PBDIT Margin (%), as of Mar 25, the value is 19.63. This value is within the healthy range. It has increased from 16.43 (Mar 24) to 19.63, marking an increase of 3.20.
- For PBIT Margin (%), as of Mar 25, the value is 18.44. This value is within the healthy range. It has increased from 15.23 (Mar 24) to 18.44, marking an increase of 3.21.
- For PBT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 13.71 (Mar 24) to 17.47, marking an increase of 3.76.
- For Net Profit Margin (%), as of Mar 25, the value is 12.03. This value exceeds the healthy maximum of 10. It has increased from 9.81 (Mar 24) to 12.03, marking an increase of 2.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has increased from 9.81 (Mar 24) to 12.04, marking an increase of 2.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.92. This value is below the healthy minimum of 15. It has increased from 13.48 (Mar 24) to 14.92, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.00. This value is within the healthy range. It has increased from 19.64 (Mar 24) to 21.00, marking an increase of 1.36.
- For Return On Assets (%), as of Mar 25, the value is 11.93. This value is within the healthy range. It has increased from 9.23 (Mar 24) to 11.93, marking an increase of 2.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has decreased from 0.19 (Mar 24) to 0.08, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.03 (Mar 24) to 1.01, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 1.92 (Mar 24) to 3.56, marking an increase of 1.64.
- For Quick Ratio (X), as of Mar 25, the value is 2.59. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 2.59, marking an increase of 1.26.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.90. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 4.90, marking a decrease of 0.02.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 20. It has increased from 2.63 (Mar 24) to 4.44, marking an increase of 1.81.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.04. This value is below the healthy minimum of 20. It has increased from 2.34 (Mar 24) to 4.04, marking an increase of 1.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.56. This value exceeds the healthy maximum of 70. It has decreased from 97.37 (Mar 24) to 95.56, marking a decrease of 1.81.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.96. This value exceeds the healthy maximum of 70. It has decreased from 97.66 (Mar 24) to 95.96, marking a decrease of 1.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 20.23. This value is within the healthy range. It has increased from 10.77 (Mar 24) to 20.23, marking an increase of 9.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.40. This value is within the healthy range. It has increased from 7.43 (Mar 24) to 13.40, marking an increase of 5.97.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,619.97. It has increased from 14,725.34 (Mar 24) to 20,619.97, marking an increase of 5,894.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.47. This value exceeds the healthy maximum of 3. It has increased from 3.52 (Mar 24) to 4.47, marking an increase of 0.95.
- For EV / EBITDA (X), as of Mar 25, the value is 22.76. This value exceeds the healthy maximum of 15. It has increased from 21.42 (Mar 24) to 22.76, marking an increase of 1.34.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 95.55. This value exceeds the healthy maximum of 70. It has decreased from 97.36 (Mar 24) to 95.55, marking a decrease of 1.81.
- For Price / BV (X), as of Mar 25, the value is 5.62. This value exceeds the healthy maximum of 3. It has increased from 4.88 (Mar 24) to 5.62, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Himadri Speciality Chemical Ltd:
- Net Profit Margin: 12.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.92% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 13.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.3 (Industry average Stock P/E: 63.16)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Carbon Black | Fortuna Tower, 23-A, Netaji Subhas Road, Kolkata West Bengal 700001 | info@himadri.com http://www.himadri.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anurag Choudhary | Chairman & M.D & CEO |
| Mr. Shyam Sundar Choudhary | Executive Director |
| Mr. Amit Choudhary | Executive Director |
| Mr. Girish Paman Vanvari | Independent Director |
| Mr. Gopal Ajay Malpani | Independent Director |
| Ms. Rita Bhattacharya | Independent Director |
| Mr. Amitabh Srivastava | Independent Director |
FAQ
What is the intrinsic value of Himadri Speciality Chemical Ltd?
Himadri Speciality Chemical Ltd's intrinsic value (as of 03 December 2025) is 370.84 which is 16.67% lower the current market price of 445.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 22,471 Cr. market cap, FY2025-2026 high/low of 607/351, reserves of ₹4,020 Cr, and liabilities of 5,518 Cr.
What is the Market Cap of Himadri Speciality Chemical Ltd?
The Market Cap of Himadri Speciality Chemical Ltd is 22,471 Cr..
What is the current Stock Price of Himadri Speciality Chemical Ltd as on 03 December 2025?
The current stock price of Himadri Speciality Chemical Ltd as on 03 December 2025 is 445.
What is the High / Low of Himadri Speciality Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Himadri Speciality Chemical Ltd stocks is 607/351.
What is the Stock P/E of Himadri Speciality Chemical Ltd?
The Stock P/E of Himadri Speciality Chemical Ltd is 34.3.
What is the Book Value of Himadri Speciality Chemical Ltd?
The Book Value of Himadri Speciality Chemical Ltd is 82.3.
What is the Dividend Yield of Himadri Speciality Chemical Ltd?
The Dividend Yield of Himadri Speciality Chemical Ltd is 0.13 %.
What is the ROCE of Himadri Speciality Chemical Ltd?
The ROCE of Himadri Speciality Chemical Ltd is 22.0 %.
What is the ROE of Himadri Speciality Chemical Ltd?
The ROE of Himadri Speciality Chemical Ltd is 16.4 %.
What is the Face Value of Himadri Speciality Chemical Ltd?
The Face Value of Himadri Speciality Chemical Ltd is 1.00.